← back to search

Chi‐Ping Day

National Institutes of Health · US
Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Immunotherapy and Immune Responses, and Cancer Genomics and Diagnostics.
h-index
22
citations
3,029
works
168
NIH funding
primary concept
Biology
email

Recent publications

Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma
Nature Communications 2025cited by 11position: middledoi
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
Nature Communications 2023cited by 64position: middledoi
A T cell resilience model associated with response to immunotherapy in multiple tumor types
Nature Medicine 2022cited by 62position: middledoi
Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk
Science Advances 2022cited by 23position: middledoi
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Science 2021cited by 859position: middledoi
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for <i>GNAQ</i> -Driven Uveal Melanoma
Clinical Cancer Research 2021cited by 75position: middledoi
Strength of immune selection in tumors varies with sex and age
Nature Communications 2020cited by 137position: middledoi
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy
Nature Medicine 2020cited by 117position: middledoi
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
Cell 2019cited by 393position: middledoi
A direct link between MITF, innate immunity, and hair graying
PLoS Biology 2018cited by 78position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Glenn Merlino · National Institutes of Health4 papers (2018–2022)Robert Saddawi‐Konefka · The University of Texas MD Anderson Cancer Center2 papers (2021–2025)Helen Michael · IDEXX Laboratories (United States)2 papers (2018–2020)Cari Smith · Center for Cancer Research2 papers (2020–2022)Kenneth Aldape · National Institute of Mental Health2 papers (2022–2022)Eytan Ruppin · Royal Marsden Hospital2 papers (2022–2025)Lauren Clubb · University of California San Diego1 papers (2025–2025)Howard H. Yang · Nanjing University of Chinese Medicine1 papers (2020–2020)Autumne N. Lee · University of Alabama at Birmingham1 papers (2018–2018)Andres Thorkelsson · Tufts University1 papers (2020–2020)Temesgen Fufa · National Human Genome Research Institute1 papers (2018–2018)Rigel J. Kishton · National Cancer Institute1 papers (2022–2022)Sridhar Hannenhalli · University of Maryland, College Park1 papers (2022–2022)Aleksandra M. Michalowski · Center for Cancer Research1 papers (2020–2020)Monica Acosta · University of California San Diego1 papers (2021–2021)Kerrie L. Marie · University of Manchester1 papers (2020–2020)Lamis Naddaf · Hebrew University of Jerusalem1 papers (2022–2022)Jiao Huang · Sun Yat-sen University Cancer Center1 papers (2022–2022)Kun Wang · University of Science and Technology of China1 papers (2025–2025)Irene Unterman · Hebrew University of Jerusalem1 papers (2022–2022)